Characteristics of vaccine- and infection-induced systemic IgA anti-SARS-CoV-2 spike responses
Characteristics of vaccine- and infection-induced systemic IgA anti-SARS-CoV-2 spike responses
Simple item page
Full item details
- dc.contributor.author
- Norton, Natasha J.
- Ings, Danielle P.
- Fifield, Kathleen E.
- Barnes, David A.
- Barnable, Keeley A.
- Harnum, Debbie O. A.
- Holder, Kayla A.
- Russell, Rodney S.
- Grant, Michael D.
- dc.date.accessioned
- 2025-02-07T15:16:53Z
- dc.date.available
- 2025-02-07T15:16:53Z
- dc.date.issued
- 2023-09-07
- dc.description.abstract - en
- Mucosal IgA is widely accepted as providing protection against respiratory infections, but stimulation of mucosal immunity, collection of mucosal samples and measurement of mucosal IgA can be problematic. The relationship between mucosal and circulating IgA responses is unclear, however, whole blood is readily collected and circulating antigen-specific IgA easily measured. We measured circulating IgA against SARS-CoV-2 spike (S) to investigate vaccine- and infection-induced production and correlation with protection. Circulating IgA against ancestral (Wuhan-Hu-1) and Omicron (BA.1) S proteins was measured at different time points in a total of 143 subjects with varied backgrounds of vaccination and infection. Intramuscular vaccination induced circulating anti-SARS-CoV-2 S IgA. Subjects with higher levels of vaccine-induced IgA against SARS-CoV-2 S (p = 0.0333) or receptor binding domain (RBD) (p = 0.0266) were less likely to experience an Omicron breakthrough infection. The same associations did not hold for circulating IgG anti-SARS-CoV-2 S levels. Breakthrough infection following two vaccinations generated stronger IgA anti-SARS-CoV-2 S responses (p = 0.0002) than third vaccinations but did not selectively increase circulating IgA against Omicron over ancestral S, indicating immune imprinting of circulating IgA responses. Circulating IgA against SARS-CoV-2 S following breakthrough infection remained higher than vaccine-induced levels for over 150 days. In conclusion, intramuscular mRNA vaccination induces circulating IgA against SARS-CoV-2 S, and higher levels are associated with protection from breakthrough infection. Vaccination with ancestral S enacts imprinting within circulating IgA responses that become apparent after breakthrough infection with Omicron. Breakthrough infection generates stronger and more durable circulating IgA responses against SARS-CoV-2 S than vaccination alone.
- dc.description.sponsorship
- This work was supported by a COVID-19 rapid research funding opportunity grant (Funding Reference Number: VR1—173202) from the Canadian Institutes for Health Research awarded through the COVID Immunity Task Force to M.D.G, R.S.R and K.A.H and by a grant from the Public Health Agency of Canada Sero-Surveillance and Research (COVID-19 Immunity Task Force Initiative) ARRANGEMENT # 2223-HQ-000284 awarded to M.G.
- dc.identifier.doi
- https://doi.org/10.3390/vaccines11091462
- dc.identifier.issn
- 2076-393X
- dc.identifier.pubmedID
- 37766138
- dc.identifier.uri
- https://open-science.canada.ca/handle/123456789/3406
- dc.language.iso
- en
- dc.publisher - en
- MDPI
- dc.rights - en
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights - fr
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights.uri - en
- https://creativecommons.org/licenses/by/4.0/
- dc.rights.uri - fr
- https://creativecommons.org/licenses/by/4.0/deed.fr
- dc.subject - en
- Health
- Coronavirus diseases
- Immunization
- dc.subject - fr
- Santé
- Maladie à coronavirus
- Immunisation
- dc.subject.en - en
- Health
- Coronavirus diseases
- Immunization
- dc.subject.fr - fr
- Santé
- Maladie à coronavirus
- Immunisation
- dc.title - en
- Characteristics of vaccine- and infection-induced systemic IgA anti-SARS-CoV-2 spike responses
- dc.type - en
- Article
- dc.type - fr
- Article
- local.acceptedmanuscript.articlenum
- 1462
- local.article.journalissue
- 9
- local.article.journaltitle - en
- Vaccines
- local.article.journalvolume
- 11
- local.pagination
- 1-13
- local.peerreview - en
- Yes
- local.peerreview - fr
- Oui
Download(s)
Original bundle
1 - 1 of 1
Name: norton-vaccine-infection-induced-systemic-IgA-anti-sars-cov-2-spike-responses.pdf
Size: 1.71 MB
Format: PDF
Collection(s)